FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2089547809> ?p ?o ?g. }

• W2089547809 endingPage "236" @default.
• W2089547809 startingPage "224" @default.
• W2089547809 abstract "Background: Coronary heart disease (CHD) is the number one cause of death in the US. The adipokine adiponectin has been studied intensively for presenting and inversed association with almost every stage of CHD. For instance, the evaluation of molecules capable of enhancing endogenous adiponectin expression is well justified. In this study, we investigated the effect of the vitamin D receptor activator (VDRA) paricalcitol and the angiotensin-converting enzyme inhibitor (ACEI) enalapril on adiponectin expression, lipid profiles, adenosine monophosphate activated protein kinase (AMPK) expression, monocyte chemo-attractant protein-1 (MCP-1), tumor necrosis factor-alpha (TNFα),cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS), antioxidant capacity, CuZn-superoxide dismutase (CuZn-SOD), Mn-SOD, NADPH p22phox subunits, inducible nitric oxidesynthase (iNOS), endothelial marker eNOS, and 81 atherosclerosis-related genes in ApoE-deficient mice. Method: Seven-week-old ApoE-deficient mice were treated for 16 weeks as follows: Group 1, ApoE vehicle control (intraperitoneal [i.p.] 100 µl propylene glycol); Group 2, ApoE-paricalcitol (200 ng i.p., 3/week); Group 3, ApoE-Enalapril (30 mg/kg daily); Group 4, ApoE-paricalcitol + enalapril (described dosing); and Group 5, wild-type control (C57BLV). Results: All treated groups presented significant changes in circulating and cardiac adiponectin, cardiac cholesterol levels, AMPK, MCP-1, TNF-α, COX-2, iNOS, eNOS, CuZn-SOD, Mn-SOD and p22phox. There were 15 genes that differed in their expression, 5 of which are involved in cardioprotection and antithrombotic mechanisms: Bcl2a1a, Col3a1, Spp1 (upregulated), Itga2, and Vwf (downregulated). Conclusion: Together, our data presented a novel role for VDRA and ACEI in reducing factors associated with CHD that may lead to the discovery of new therapeutic venues." @default.
• W2089547809 created "2016-06-24" @default.
• W2089547809 creator A5045377713 @default.
• W2089547809 creator A5067591674 @default.
• W2089547809 creator A5082331984 @default.
• W2089547809 date "2014-07-18" @default.
• W2089547809 modified "2023-10-02" @default.
• W2089547809 title "Adiponectin expression and the cardioprotective role of the vitamin D receptor activator paricalcitol and the angiotensin converting enzyme inhibitor enalapril in ApoE-deficient mice" @default.
• W2089547809 cites W1587875569 @default.
• W2089547809 cites W1647933556 @default.
• W2089547809 cites W1859624620 @default.
• W2089547809 cites W1889956147 @default.
• W2089547809 cites W1964814161 @default.
• W2089547809 cites W1966225243 @default.
• W2089547809 cites W1968124526 @default.
• W2089547809 cites W1969573745 @default.
• W2089547809 cites W1970223241 @default.
• W2089547809 cites W1994784206 @default.
• W2089547809 cites W1994915655 @default.
• W2089547809 cites W1996463069 @default.
• W2089547809 cites W1998482930 @default.
• W2089547809 cites W2000794212 @default.
• W2089547809 cites W2002920137 @default.
• W2089547809 cites W2012663953 @default.
• W2089547809 cites W2021298478 @default.
• W2089547809 cites W2023907177 @default.
• W2089547809 cites W2028302756 @default.
• W2089547809 cites W2030611470 @default.
• W2089547809 cites W2033332566 @default.
• W2089547809 cites W2033507886 @default.
• W2089547809 cites W2035252462 @default.
• W2089547809 cites W2035980304 @default.
• W2089547809 cites W2041963174 @default.
• W2089547809 cites W2043958887 @default.
• W2089547809 cites W2046618596 @default.
• W2089547809 cites W2048890665 @default.
• W2089547809 cites W2050312701 @default.
• W2089547809 cites W2050856345 @default.
• W2089547809 cites W2060363095 @default.
• W2089547809 cites W2062715867 @default.
• W2089547809 cites W2063444278 @default.
• W2089547809 cites W2064956583 @default.
• W2089547809 cites W2074505791 @default.
• W2089547809 cites W2076280162 @default.
• W2089547809 cites W2079738970 @default.
• W2089547809 cites W2088829415 @default.
• W2089547809 cites W2103198329 @default.
• W2089547809 cites W2107865201 @default.
• W2089547809 cites W2108810165 @default.
• W2089547809 cites W2110871895 @default.
• W2089547809 cites W2111116814 @default.
• W2089547809 cites W2112461500 @default.
• W2089547809 cites W2115291009 @default.
• W2089547809 cites W2117760446 @default.
• W2089547809 cites W2120276758 @default.
• W2089547809 cites W2120823449 @default.
• W2089547809 cites W2123714940 @default.
• W2089547809 cites W2124821727 @default.
• W2089547809 cites W2124861138 @default.
• W2089547809 cites W2132725893 @default.
• W2089547809 cites W2136114093 @default.
• W2089547809 cites W2141608973 @default.
• W2089547809 cites W2146266563 @default.
• W2089547809 cites W2153366902 @default.
• W2089547809 cites W2156260257 @default.
• W2089547809 cites W2156641994 @default.
• W2089547809 cites W2158372214 @default.
• W2089547809 cites W2163823318 @default.
• W2089547809 cites W2168910092 @default.
• W2089547809 cites W2184009762 @default.
• W2089547809 cites W4292022394 @default.
• W2089547809 doi "https://doi.org/10.1177/1753944714542593" @default.
• W2089547809 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4389636" @default.
• W2089547809 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25037058" @default.
• W2089547809 hasPublicationYear "2014" @default.
• W2089547809 type Work @default.
• W2089547809 sameAs 2089547809 @default.
• W2089547809 citedByCount "15" @default.
• W2089547809 countsByYear W20895478092015 @default.
• W2089547809 countsByYear W20895478092016 @default.
• W2089547809 countsByYear W20895478092017 @default.
• W2089547809 countsByYear W20895478092018 @default.
• W2089547809 countsByYear W20895478092019 @default.
• W2089547809 countsByYear W20895478092020 @default.
• W2089547809 countsByYear W20895478092022 @default.
• W2089547809 countsByYear W20895478092023 @default.
• W2089547809 crossrefType "journal-article" @default.
• W2089547809 hasAuthorship W2089547809A5045377713 @default.
• W2089547809 hasAuthorship W2089547809A5067591674 @default.
• W2089547809 hasAuthorship W2089547809A5082331984 @default.
• W2089547809 hasBestOaLocation W20895478091 @default.
• W2089547809 hasConcept C126322002 @default.
• W2089547809 hasConcept C134018914 @default.
• W2089547809 hasConcept C170493617 @default.
• W2089547809 hasConcept C2775838275 @default.
• W2089547809 hasConcept C2776108821 @default.
• W2089547809 hasConcept C2776151105 @default.
• W2089547809 hasConcept C2776782570 @default.

• next